BioVie Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.43 USD (Oct 30, 2026, 3:25 PM EDT) · Market cap 10.79M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. It also develops Bezisterim, an investigational, novel, orally administered small molecule that is In Phase 3 clinical trial for the treatment of patients with mild to moderate Alzheimer’s disease; and in Phase 2b clinical trial to treat Parkinson’s disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Details
| Name | BioVie Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 13 |
| Founded | 2013 |
| Ceo | Cuong Viet Do |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| Isin | US09074F5044 |
| Cusip | 09074F504 |
| Cik | 1580149 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Cuong Viet Do M.B.A. | President, Chief Executive Officer and Director |
| Joanne Wendy Kim C.P.A. | Chief Financial Officer, Treasurer and Corporate Secretary |
| Dr. Joseph M. Palumbo M.D. | Executive Vice President of Research & Development and Chief Medical Officer |
| Clarence N. Ahlem | Senior Vice President of Operations |
| Dr. Penelope Markham Ph.D. | Senior Vice President of Liver Disease and Long COVID Programs |
| Denise Smith | Senior Vice President of Manufacturing and Development |
| Dr. Christopher L. Reading Ph.D. | Senior Vice President of Alzheimer's Disease Program |
| David Morse | Senior Vice President and Chief Regulatory Officer |
Contact
| Address | 680 W. Nye Lane, Suite 2014, Carson City, Nevada 89703, United States |
| Phone | 775 888 3162 |
| Website | https://bioviepharma.com |